Global Cell Culture Media Market for Regenerative Medicines 2024–2033

Reports Description

As per the current market research conducted by CMI Team, the Global Cell Culture Media Market for Regenerative Medicines is expected to record a CAGR of 12.4% from 2023 to 2032. In 2022, the market size is projected to reach a valuation of USD 4,079 Million. By 2032, the valuation is anticipated to reach USD 11799 Million.

Cell Culture Media Market for Regenerative Medicines: Overview

Cell culture media, often known as growth media, is a term for any gel or liquid designed to promote cellular development in an enclosed environment. When cells, organs, or tissues are extracted from living species, they must be kept in a suitable artificial environment; hence, a culture media plays an important part in cell culture technology, facilitating in vitro cellular research.

The medium provides the nutrients required for cell cultures to survive and grow. The growth media also has the proper osmolality and pH. Regenerative medicine, on the other hand, tries to repair tissue or organs that have been destroyed by illness, trauma, or congenital abnormalities. Tissue engineering, cellular therapy, medicinal gadgets, and artificial organs all involve regenerative medicines.

Cell Culture Media Market for Regenerative Medicines: Regulatory Analysis

A medication is eligible for regenerative medicine advanced treatment (RMAT) designation, as defined in U.S. Section 3033 of the 21st Century Cures Act.

The drug is a regenerative medicine therapy, which is described as cell therapy, therapeutic tissue-engineered commodity, cell line and tissue product, or any combination product using such therapies or products, except for those regulated solely under Section 361 of the Public Health Service Act and part 1271 of Title 21, Code of Federal Regulations.

The drug is intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition; and the drug is intended to treat, modify, reverse, or cure.

According to preliminary clinical evidence, the medicine has the potential to meet unmet medical requirements for such an illness or condition. Certain human gene therapies and xenogeneic cell products may also fit the criteria of a regenerative medicine therapy, according to the FDA’s interpretation of Section 506(G) of the Federal Food, Drug, and Cosmetic Act (as amended by Section 3033 of the 21st Century Cures Act).

Global Cell Culture Media Market for Regenerative Medicines: Growth Drivers

Increasing prevalence of chronic ailments

In the current decade, the work-life schedule of the global population has turned hectic, and due to this, they have adopted poor eating habits. Poor eating habits are leading to serious health problems such as high cholesterol, vitamin & mineral deficiency, low bone density, and others. The consumption of processed food, especially, consumption of processed meat products is increasing day by day.

Processed meat products contain nitrites which convert into carcinogens which is a potent compound that causes cancer. Additionally, the deterioration of the environment and rise in pollutants contribute to the development of chronic, life-threatening illnesses including cancer and asthma. The increasing prevalence of developing chronic diseases in the global population increases the requirement and demand for regeneration medicines. Regeneration medicines offer fast healing and work better than other treatments, which has helped in producing better results.

Global Cell Culture Media Market for Regenerative Medicines: Segmentation Analysis

The Cell Culture Media Market for Regenerative Medicines is segmented based on product, type, and region. On the basis of product, it is segmented into serum-free media, classical media, stem cell culture media, specialty media, chemically defined media, and other cell culture media. On the basis of type, it is segmented into liquid media and semi-solid & solid media. On the basis of region, it is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

According to the global Cell Culture Media Market for Regenerative Medicines analysis, based on product, the serum-free media segment gained a major share in the global market in 2021 and is expected to sustain its market share during the forecast period.

The use of serum-free medium (SFM) is an essential instrument that allows cell culture to be conducted with a predetermined set of circumstances that are as devoid of confounding factors as feasible. Rapidly expanding biopharmaceutical industries and rising production of regeneration medicine output are paving the way for the growth of serum-free media in the market.

According to the global Cell Culture Media Market for Regenerative Medicines trends, based on type, the liquid segment gained a major share in the market in 2021 and is expected to sustain its market share during the forecast period. With the quick mycobacterial growth and a high rate of isolation, a growing number of biologics and biosimilar producers, both downstream and upstream, are converting from premixed powders to liquid mediums.

Furthermore, liquid media decreases the risk of harmful exposure and makes production & development more versatile than solid media. Furthermore, ready-to-use liquid media removes the requirement for mixing vessels, balances, and the installation of a water for injection (WFI) loop, all of which are required when mixing powder media.

According to the global Cell Culture Media Market for Regenerative Medicines trends, based on region, the North American region gained a major share of the market in 2021 and is expected to sustain its market share during the forecast period. The exponential growth is linked to the rise of the biomedical and pharmaceutical sectors, the increasing number of licenses for cell culture-based regenerative therapy, and the rising prevalence of illnesses such as cancer, and investment and financing in cell-based research.

Increased government research initiatives, the development of new technologies and developments in cell culture applications, medical trials on cancer, and the existence of world-class biotechnology and research institutes in the area are expected to drive market expansion in North America.

Report Scope

Key Insights:

• Based on product segmentation, the serum-free media segment is estimated to hold the largest market share during the forecast period.
• Based on type, the liquid media segment is the leading revenue-generating category during the forecast period.
• Based on region, North America is the leading revenue-generating category during the forecast period.

Recent Development

• In July 2016, ThermoFisher Scientific Inc. introduced a new Thermo scientific pre-weigh dehydrated culture media to expand its product offering,
• In June 2017, Cell Culture Technologies launched SteMaxOne medium for human mesenchymal stem cells and stem cell lines to extend its product portfolio and client base. This medium is devoid of protein and peptides.

Regional Landscape

Throughout the projection period, North America is likely to remain one of the most appealing regions, accounting for the bulk of market revenue. This significant proportion may be linked to the rise of the biomedical and pharmaceutical sectors, the increasing number of licenses for cell culture-based regenerative therapy, and the rising prevalence of illnesses such as cancer, and investment and financing in cell-based research.

Increased government research initiatives, the development of new technologies and developments in cell culture applications, medical trials on cancer, and the existence of world-class biotechnology and research institutes in the area are expected to drive market expansion in North America.

Competitive Landscape

Our report offers both quantitative and qualitative insights into the Cell Culture Media Market for Regenerative Medicines and major development initiatives adopted by the key players. Further, it offers competitive details and market share analysis. The report further includes relevant financial information, products and services offered, SWOT analysis, and recent developments of the players profiled.

List of the prominent players in the global Cell Culture Media Market for Regenerative Medicines:

• Thermo Fisher Scientific Inc.
• Merck KGaA
• CYTIVA
• Sartorius AG
• FUJIFILM Irvine Scientific Inc.
• Lonza Group AG
• InvivoGen
• STEMCELL Technologies Inc.
• PromoCell GmbH
• Cell Biologics Inc.
• Others

The global Cell Culture Media Market for Regenerative Medicines is segmented as follows:

By Product

• Serum-free Media
• Classical Media
• Stem Cell Culture Media
• Specialty Media
• Chemically Defined Media
• Other Cell Culture Media

By Type

• Liquid Media
• Semi-Solid and Solid Media

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America